Publication | Closed Access
Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutations
14
Citations
11
References
2016
Year
Gefitinib Predict EfficacyOncologyMedicinePathologyPharmacokinetic ParametersBronchial NeoplasmCancer TreatmentEgfr MutationsPharmacologyRadiation OncologyLung Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1